Project

Retrospective and prospective registry of patients with metastatic NSCLC harboring typical and atypical EGFR mutations

Ongoing - recruitment active · 2023 until 2030

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2023
End Date
2030
Financing
SAKK
Labels
lung cancer
Brief description/objective